Gastrointestinal Cancer News

Many patients with stage IV metastatic cancer who died within a month of diagnosis received cancer-related treatment, according to study in JNCI Cancer Spectrum.

Hyperprogressive disease did not appear to be related to clinically significant adverse events, age, tumor type or type of immunotherapy among patients with solid tumors in early-phase trials, according to results of a retrospective study published in Cancer.

A novel combination blood test detected nearly 70% of pancreatic cancers with a false-positive rate less than 5%, according to study findings published in Clinical Cancer Research.

The addition of nanoparticle albumin-bound (nab)-paclitaxel to standard gemcitabine-cisplatin therapy improved median PFS and OS among patients with advanced biliary tract cancers compared with data from historical controls, according to results from a phase 2 trial published in JAMA Oncology. 

High adherence to statins may have beneficial effects beyond cholesterol management, including risk reduction for colon and rectal cancers, according to findings published in Nutrition, Metabolism and Cardiovascular Diseases.

Three large populations of older cancer survivors demonstrated varying degrees of chronic opioid use, with colorectal and lung cancer survivors showing higher rates of chronic use 1 year after diagnosis than matched controls without cancer, according to a study published in Journal of Clinical Oncology.

Carl H. June , MD, is about to receive an award for his life’s work — it's not his first and it certainly won’t be his last. Yet, he remains humble about the accolades.

Residual confounding, and not an endoscopist’s personal characteristics like surgical specialty training or sex, may be responsible for previously identified differences in adenoma detection rates and proximal sessile serrated polyp detection rates during colonoscopy, according to results of a single-center study published inJAMA Surgery.

PHILADELPHIA — Initiating colorectal cancer screening in patients younger than 50 years has recently sparked debate and a need for primary care physicians to consider the benefits and downfalls of testing in this age group, according to a presentation at the ACP Internal Medicine Meeting.

Three neoadjuvant chemotherapy-related factors appeared associated with improved survival among patients with advanced pancreatic cancer who are candidates for tumor resection, according to study results published in Annals of Surgery.